HLA-B and neoplasm: Given the potential relevance of this response regarding tumor immunogenicity, and eventually for leveraging the efficacy of ICI-based therapies, we validated the effect of CM272 on the expression of chemokine CCL5 and different MHC genes such as HLA-A, HLA-B and HLA-C (Fig. 5A and Fig. S4A).